1 / 8

Cost vs. Benefits of RFID Implementation in the Pharmaceutical Industry

Edward M. Keefe. Cost vs. Benefits of RFID Implementation in the Pharmaceutical Industry. The Supply Chain. More complex than retail Drugs sold to end user at different prices Medicaid Medicare Hospitals Pharmacies Large retailers. Problems in The Supply Chain. Diversion

jeanne
Download Presentation

Cost vs. Benefits of RFID Implementation in the Pharmaceutical Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Edward M. Keefe Cost vs. Benefits of RFID Implementation in the Pharmaceutical Industry

  2. The Supply Chain • More complex than retail • Drugs sold to end user at different prices • Medicaid • Medicare • Hospitals • Pharmacies • Large retailers

  3. Problems in The Supply Chain • Diversion • Discounted drug are sold on open market • Sold on black market • Counterfeiting • Copies of drugs enter the market

  4. The Issue • Costs vs. Benefits Of Implementation • Costs • Price • Untested in industry • Benefits • Stop counterfeiting and diversion • Public Safety

  5. General Issue • Implementation of New Technology • Using the implementation of new technology in industry as benchmark • Using the success or failures of RFID implementation in others industries as a guide

  6. What is RFID? • Radio-frequency identification • Uses radio waves to transmit the identification and other unique information • Integrated circuit and Antenna • Passive • Active • Semi-passive

  7. Evidence of Difficulty • Hype • Agencies trying to implement drug tracking • Failures vs. Successes • Discussion if actual per unit costs are too high

  8. Stakeholders • Pharmaceutical Companies • FDA • States and Regulatory Agencies • Public • RFID producers

More Related